WoundSource Page Designs_White Papers small

A New Approach to Managing Wound Exudate During Challenging Times

A New Approach to Managing Wound Exudate During Challenging Times
 

Managing wounds with moderate to high amounts of exudate can be challenging, even under the best of circumstances. The coronavirus disease 2019 (COVID-19) pandemic has complicated the care of patients with high-exudating wounds because these patients often have comorbidities that predispose them to serious complications of COVID-19. Consequently, clinicians and patients are interested in reducing the number of in-person wound care visits.

This informative white paper, sponsored by HARTMANN USA, makers of Zetuvit Plus, discusses the need for effective high-exudate wound management when in-person wound care is not possible. It also provides details and clinical case studies of Zetuvit Plus, a four-layer polymer dressing designed to absorb large amounts of exudate. Dressing changes are minimized because Zetuvit Plus is changed only when saturated. Highly rated Zetuvit Plus is an ideal product to consider at a time when many patients are dressing their own wounds at home.

Wound care professionals will be interested in this white paper, which answers the question, “How can patients best manage their high-exudating wounds on their own?”

This white paper covers the following topics:

Wound care challenges posed by the COVID-19 pandemic
Comorbidities contributing to COVID-19 complication risk
Issues related to high wound exudate
Need to minimize dressing changes in the pandemic
Properties and mechanisms of Zetuvit Plus suberabsorbent dressing
Zetuvit Plus case studies

This paper is written for wound care clinicians and purchasing directors with an interest in product solutions.

Sponsored by HARTMANN USA

Managing wounds with moderate to high amounts of exudate can be challenging, even under the best of circumstances. The coronavirus disease 2019 (COVID-19) pandemic has complicated the care of patients with high-exudating wounds because these patients often have comorbidities that predispose them to serious complications of COVID-19. Consequently, clinicians and patients are interested in reducing the number of in-person wound care visits.

This informative white paper, sponsored by HARTMANN USA, makers of Zetuvit Plus, discusses the need for effective high-exudate wound management when in-person wound care is not possible. It also provides details and clinical case studies of Zetuvit Plus, a four-layer polymer dressing designed to absorb large amounts of exudate. Dressing changes are minimized because Zetuvit Plus is changed only when saturated. Highly rated Zetuvit Plus is an ideal product to consider at a time when many patients are dressing their own wounds at home.

Wound care professionals will be interested in this white paper, which answers the question, “How can patients best manage their high-exudating wounds on their own?”

This white paper covers the following topics:

Wound care challenges posed by the COVID-19 pandemic
Comorbidities contributing to COVID-19 complication risk
Issues related to high wound exudate
Need to minimize dressing changes in the pandemic
Properties and mechanisms of Zetuvit Plus suberabsorbent dressing
Zetuvit Plus case studies

This paper is written for wound care clinicians and purchasing directors with an interest in product solutions.

Sponsored by HARTMANN USA

WoundSource
The World’s Definitive Source for Wound Care & Product Information